Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $54.63 | 3 | 57.8% |
| Education | $39.81 | 3 | 42.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $22.97 | 1 | $0 (2017) |
| Incyte Corporation | $20.13 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $11.92 | 1 | $0 (2021) |
| PFIZER INC. | $11.53 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $10.87 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.02 | 1 | Regeneron Healthcare Solutions, Inc. ($17.02) |
| 2021 | $22.79 | 2 | Gilead Sciences, Inc. ($11.92) |
| 2017 | $54.63 | 3 | Amgen Inc. ($22.97) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 01/26/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $10.87 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2017 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/07/2017 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Endocrinology | ||||||
| 01/28/2017 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $20.13 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 92 | 136 | $48,726 | $12,556 |
| 2022 | 4 | 79 | 153 | $53,213 | $13,994 |
| 2021 | 5 | 90 | 165 | $48,519 | $13,765 |
| 2020 | 5 | 113 | 189 | $51,363 | $10,493 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 23 | 39 | $13,143 | $3,997 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 27 | $16,632 | $3,463 | 20.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 29 | $9,193 | $2,608 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 31 | 41 | $9,758 | $2,488 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 24 | 74 | $24,938 | $7,176 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $11,704 | $2,888 | 24.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 29 | $9,193 | $2,309 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 31 | $7,378 | $1,621 | 22.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 21 | 54 | $18,198 | $6,327 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 47 | $11,186 | $3,377 | 30.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 25 | $7,925 | $2,063 | 26.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 13 | 19 | $6,270 | $1,207 | 19.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 20 | $4,940 | $791.37 | 16.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 26 | 51 | $17,187 | $3,477 | 20.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 38 | 63 | $14,994 | $3,302 | 22.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 15 | 31 | $9,588 | $2,010 | 21.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 20 | 30 | $7,410 | $1,244 | 16.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 14 | 14 | $2,184 | $459.34 | 21.0% |
About Dr. Om Pandey, M.D
Dr. Om Pandey, M.D is a Hematology & Oncology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316927353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Om Pandey, M.D has received a total of $94.44 in payments from pharmaceutical and medical device companies, with $17.02 received in 2024. These payments were reported across 6 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($54.63).
As a Medicare-enrolled provider, Pandey has provided services to 374 Medicare beneficiaries, totaling 643 services with total Medicare billing of $50,808. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine
- Location Austin, TX
- Active Since 01/17/2006
- Last Updated 01/29/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1316927353
Products in Payments
- Prolia (Biological) $22.97
- LIBTAYO (Biological) $17.02
- BOSULIF (Drug) $11.53
- KEYTRUDA (Biological) $10.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Austin
Dr. Debra Patt, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $109,909
Uttam Rao
Hematology & Oncology — Payments: $19,966
Dr. Allison Gorrebeeck, Md, MD
Hematology & Oncology — Payments: $5,624
Dr. Richard Helmer, M.d, M.D
Hematology & Oncology — Payments: $3,540
Vinod Kondragunta
Hematology & Oncology — Payments: $3,490
Dr. Shubhada Shrikhande, Md, MD
Hematology & Oncology — Payments: $1,469